Skip to main content
Fig.14 | BMC Neurology

Fig.14

From: Diagnostic biomarkers and immune infiltration profiles common to COVID-19, acute myocardial infarction and acute ischaemic stroke using bioinformatics methods and machine learning

Fig.14

Expression of S100 A12 in the validation dataset. A The expression of S100 A12 was increased and significant in the COVID-19 group relative to the HC group. B The expression of S100 A12 was increased and significant in the AMI group relative to the HC group. C The expression of S100 A12 was increased and meaningful in the AIS group relative to the HC group. Orange indicates the disease group and blue indicates the normal group, P values are shown as *, P < 0.05; **, P < 0.01; ***, P < 0.001

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us